Drugs / S1 [arm: active_comparator] — S-1:40\~60mg Bid, d1\~14, q3w;
S1 [arm: active_comparator] — S-1:40\~60mg Bid, d1\~14, q3w;
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT04367025 Comparator | May 2020 → May 2022 | gastric cancer | Chinese PLA General Hospital | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | S1 [arm: active_comparator] — S-1:40\~60mg Bid, d1\~14, q3w; | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04367025 ↗ |